kt alpha Co., Ltd. (KOSDAQ:036030)
South Korea · Delayed Price · Currency is KRW 4,970.00
+10.00 (0.20%)
At close: Sep 18, 2026
kt alpha Market Cap
kt alpha has a market cap or net worth of 243.63 billion as of September 18, 2026. Its market cap has decreased by -7.62% in one year.
Market Cap
243.63B
Enterprise Value
-14.46T
Revenue
596.45B
Ranking
n/a
PE Ratio
12.22
Stock Price
4,970.00
ChartMarket Cap Chart
Since November 23, 2000, kt alpha's market cap has increased from 179.06B to 243.63B, an increase of 36.06%. That is a compound annual growth rate of 1.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 243.63B | -8.64% |
| Dec 30, 2025 | 266.66B | 54.55% |
| Dec 30, 2024 | 172.55B | -41.24% |
| Dec 28, 2023 | 293.62B | 10.31% |
| Dec 29, 2022 | 266.17B | -25.21% |
| Dec 30, 2021 | 355.88B | 73.29% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Maeil Dairies | 248.45B |
| AeroSpace Technology of Korea | 246.30B |
| Cape Industries | 246.26B |
| Next Biomedical | 245.42B |
| IMBiologics | 245.25B |
| Wooyang HC | 244.49B |
| HEM Pharma | 244.39B |
| COOCON | 244.22B |